Phillip G. Claringbold
- Oncology top 5%
- Epidemiology top 5%
- Neurology top 5%
- Radiology, Nuclear Medicine and Imaging top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- J. Harvey TurnerR. Arlen PriceMurali KesavanDavid M. HurleyGregory S Y OngP. Gerry FeganMichael F. LeahyJ Bouček
- Topics
- Neuroendocrine Tumor Research Advances (10 papers)Neuroblastoma Research and Treatments (8 papers)Lung Cancer Research Studies (8 papers)
- Cited by
- NeurologyOncologyEpidemiology
- Partner nations
- AustraliaUnited States
In The Last Decade
Phillip G. Claringbold
12 papers receiving 680 citations
Peers
Comparison fields: 5 of 39
- Oncology 536
- Epidemiology 528
- Neurology 427
- Radiology, Nuclear Medicine and Imaging 200
- Pulmonary and Respiratory Medicine 80
Countries citing papers authored by Phillip G. Claringbold
This map shows the geographic impact of Phillip G. Claringbold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip G. Claringbold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip G. Claringbold more than expected).
Fields of papers citing papers by Phillip G. Claringbold
This network shows the impact of papers produced by Phillip G. Claringbold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip G. Claringbold. The network helps show where Phillip G. Claringbold may publish in the future.
Co-authorship network of co-authors of Phillip G. Claringbold
This figure shows the co-authorship network connecting the top 25 collaborators of Phillip G. Claringbold. A scholar is included among the top collaborators of Phillip G. Claringbold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip G. Claringbold. Phillip G. Claringbold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 19 | |
| 3 | 1 | |
| 4 | 79 | |
| 5 | 74 | |
| 6 | 53 | |
| 7 | 131 | |
| 8 | 41 | |
| 9 | 165 | |
| 10 | Lutetium-177 octreotate radiopeptide therapy of endocrine cancer: Tumor and critical organ dosimetry | 1 |
| 11 | 37 | |
| 12 | 79 |
About Phillip G. Claringbold
Phillip G. Claringbold is a scholar working on Neurology, Oncology and Epidemiology, having authored 12 papers that have together received 695 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (10 papers), Neuroblastoma Research and Treatments (8 papers) and Lung Cancer Research Studies (8 papers). The work is most often cited by research in Neurology (427 citations), Oncology (536 citations) and Epidemiology (528 citations). Phillip G. Claringbold has collaborated with scholars based in Australia and United States. Frequent co-authors include J. Harvey Turner, R. Arlen Price, Murali Kesavan, David M. Hurley, Gregory S Y Ong, P. Gerry Fegan, Michael F. Leahy, J Bouček, David Henley and Wei‐Sen Lam. Their work appears in journals such as Journal of Clinical Oncology, Cancer and European Journal of Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.